Abiopharma

BioNTech to Host Innovation Series R&D Day on November 11, 2025

BioNTech veranstaltet am 11. November 2025 „Innovation Series Day“ zu Forschung & Entwicklung

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

New Form 6-K - ONCOLYTICS BIOTECH INC Filed: 2025-10-28 AccNo: 0001129928-25-000084 Size: 41 KB

(10% Negative) Kiniksa Pharmaceuticals International, plc (KNSA) Announces Delay in increase Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

Alto Neuroscience to Participate in Upcoming Investor Conferences

New Form 25 - Adaptimmune Therapeutics PLC Filed: 2025-10-28 AccNo: 0001104659-25-102828 Size: 15 KB

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

(10% Negative) Unicycive Therapeutics, Inc. (UNCY) Announces Clinical Trial Timeline Adjustment

Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution

TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI

Context Therapeutics to Participate in Upcoming Investor Conferences

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

New Form 6-K - GSK plc Filed: 2025-10-28 AccNo: 0001654954-25-012259 Size: 37 KB